ANGPTL4 and proliferative diabetic retinopathy: These results indicate that targeting ANGPTL-4, either alone or in combination with profilin-1, could serve as an effective therapeutic strategy and potential diagnostic biomarker for proliferative diabetic retinopathy and other vitreoretinal inflammatory diseases [65].